Moderna (MRNA) is back in focus after completing a clinical study of multiple mRNA vaccines targeting several respiratory ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

Uğur Şahin and Özlem Türeci, a Turkish husband-and-wife team, became unlikely celebrities during the pandemic for their world ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering ...

The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.

BioNTech's co-founders Ugur Sahin and Oezlem Tuereci plan to leave the company by 2026 to establish a new venture focused on mRNA technology. While ensuring BioNTech's existing operations continue ...

BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...

A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...

Scientists developed a new mRNA platform that keeps vaccines and therapies effective in older adults and patients with obesity, where current treatments often lose potency.